logo

For the Inventor, By the Inventor

Nagano, Japan

Atsushi Tsubaki

This inventor holds 5 USPTO granted patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 1991-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Tsubaki. Retrieved from https://idiyas.com/inventor/atsushi-tsubaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Nagano, JP (1991 - 1993)
  • Matsumoto, JP (1992 - 1993)

Company Filing History:

goldMedal5 out of 176 
 
Kissei Pharmaceutical Co., Ltd.
 patents

Years Active: 1991-1993

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5202335 - Succinic acid compounds (1993-04-13),
2. 5177069 - Naphthysulfonylalkanoic acid compounds and pharmaceutical compositions (1993-01-05),
3. 5145869 - Phenylsulfonylalkanoic acid compounds and pharmaceuticals thereof (1992-09-08),
4. 5073553 - 3-alkoxy substituted benzofuro[3,2-c]quinolin-6-one compounds (1991-12-17),
5. 5023261 - Acylated benzofuro[3,2-c]quinoline compounds with utility as treatments (1991-06-11),

Title: The Innovations of Atsushi Tsubaki

Introduction

Atsushi Tsubaki is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance insulin secretion and treat various medical conditions. With a total of 5 patents to his name, Tsubaki's work is recognized for its potential impact on healthcare.

Latest Patents

Tsubaki's latest patents include innovative compounds such as succinic acid compounds. These compounds are designed to enhance insulin secretion and possess hypoglycemic activity, making them useful for the treatment of diabetes. The specific formula involves a heterocyclic group, cycloalkyl group, or phenyl group, along with various substituents. Another significant patent involves naphthysulfonylalkanoic acid compounds, which are beneficial for the prevention or treatment of irritable bowel syndrome, biliary dyskinesia, and acute pancreatitis.

Career Highlights

Atsushi Tsubaki is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic options for patients suffering from chronic conditions.

Collaborations

Tsubaki has collaborated with notable colleagues such as Michihiro Kobayashi and Tetsuhide Kamijo. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Atsushi Tsubaki's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…